Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF | Spanish ecancer 12 816 / https://doi.org/10.3332/ecancer.2018.816

Case Report

Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma

Duodenal adenocarcinoma (ADC) represents only 0.3% of gastrointestinal neoplasms. With the frequency being higher between the ages of 40 and 60, it is predominantly located in the second part of the duodenum and around the periampullary region. Symptoms are nonspecific, so the majority of patients present with advanced disease. Neoadjuvant chemotherapy is a therapeutic option that has not been well studied. The global literature includes only isolated reports on this subject. This is why we are presenting the following case: a 60-year-old female patient with a locally advanced, inoperable duodenal ADC received neoadjuvant chemotherapy. Having presented a favourable response as observed in the post-neoadjuvant extension studies, a pancreaticoduodenectomy was performed without any perioperative complications and with satisfactory progress. The final biopsy reported a complete pathological response. After being monitored for 34 months, the patient was free from locoregional and distant metastatic disease. During the last weeks of monitoring, she developed a second primary breast tumour, which has been corroborated by immunohistochemistry.

Keywords: duodenal adenocarcinoma, neoadjuvant therapy

Loading Article Metrics ... Please wait

Related articles

Research: The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria

Abstract | Full Article | PDF Published: 13 Jun 2018 / https://doi.org/10.3332/ecancer.2018.843

Research: Prostate-specific antigen-based screening in Afro-Caribbean men: a survey of members of the Caribbean Urological Association

Abstract | Full Article | PDF Published: 11 Jun 2018 / https://doi.org/10.3332/ecancer.2018.842

Case Report: Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen

Abstract | Full Article | PDF Published: 07 Jun 2018 / https://doi.org/10.3332/ecancer.2018.841

Review: Are aggressive epithelial cancers ‘a disease’ of Eutherian mammals?

Abstract | Full Article | PDF Published: 04 Jun 2018 / https://doi.org/10.3332/ecancer.2018.840

Research: Neoplasm of uncertain behaviour of the breast—a retrospective study in a breast unit

Abstract | Full Article | PDF Published: 31 May 2018 / https://doi.org/10.3332/ecancer.2018.839



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence